Theresa Matkovits

Chief Development Officer at Matinas BioPharma Holdings, Inc.

Theresa Matkovits

Theresa Matkovits

Chief Development Officer at Matinas BioPharma Holdings, Inc.

Biography

Theresa Matkovits is on the board of BioSurplus, Inc. and Appili Therapeutics, Inc. and Chief Development Officer for Matinas BioPharma Holdings, Inc. and Vice President for The Medicines Co. In her past career Dr. Matkovits was Chief Operating Officer for Hepion Pharmaceuticals, Inc. and Head-Strategic Planning & Operations at Novartis AG. Theresa Matkovits received an undergraduate degree from Alfred University and a doctorate from the University of Medicine & Dentistry of New Jersey.

Overview
Career Highlights

Hepion Pharmaceuticals, Inc.

RelSci Relationships

518

Number of Boards

3

Birthday

1968

Age

52

Relationships
RelSci Relationships are individuals Theresa Matkovits likely has professional access to. A relationship does not necessarily indicate a personal connection.

Manager at SJF MANAGEMENT LLC

Relationship likelihood: Strong

Director at BioSurplus, Inc.

Relationship likelihood: Strong

Director at BioSurplus, Inc.

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at BioSurplus, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Director at KI Investment Holdings LLC

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at BioSurplus, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Appili Therapeutics, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Matinas BioPharma Holdings, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Appili Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Matinas BioPharma Holdings, Inc.

Relationship likelihood: Strong

Paths to Theresa Matkovits
Potential Connections via
Relationship Science
You
Theresa Matkovits
Chief Development Officer at Matinas BioPharma Holdings, Inc.
Education
Class of 1994

The University of Medicine and Dentistry of New Jersey (UMDNJ) was a state-run health sciences institution of New Jersey, United States. It had eight distinct academic units. It formed an academic health sciences centre.

Alfred University is a small, comprehensive university in the Village of Alfred, Allegany County in Western New York, USA, south of Rochester and southeast of Buffalo. Alfred was founded in 1836 as the Select School by Seventh Day Baptists as a non-sectarian institution. Unusual for the time, the school was co-educational. It was also racially integrated, and enrolled its first African-American student and two Native American students in the 1850s, becoming the second college in the nation to do so.

Career History
Chief Development Officer
2018 - Current

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B; and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded in May 2013 and is headquartered in Bedminster, NJ.

Chief Operating Officer
2015 - 2018

Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Head-Strategic Planning & Operations
1997 - 2010

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Theresa Matkovits. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Theresa Matkovits's profile does not indicate a business or promotional relationship of any kind between RelSci and Theresa Matkovits.